Compound Detail
CHEMBL395994
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL395994 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | MUGBUMZPPNMDIT-INIZCTEOSA-N |
2
Targets
4
Activities
1
Assay Types
0
PK Parameters
5
Publications
0
Known Names
Molecular Properties
365.4
MW (Da)
3.69
ALogP
5
HBA
1
HBD
51.2
PSA (Ų)
0.71
QED
0
Ro5 Violations
4
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 4 meas. best 6.16
Target Activity Profile
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| A549 | IC50 | = | 700.0 | nM | 6.16 | Cytotoxicity against human A549 cells by SRB microtiter plate assay | 17585747 |
| Unchecked | IC50 | = | 19000.0 | nM | 4.72 | Inhibition of GRE-mediated transcription in human HepG cells | 18077159 |
| Unchecked | IC50 | = | 21000.0 | nM | 4.68 | Inhibition of NF-kappaB-mediated transcription in human HepG cells | 18077159 |
| Unchecked | IC50 | = | 24000.0 | nM | 4.62 | Inhibition of CRE-mediated transcription in human HepG cells | 18077159 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 18077159 | 10.1016/j.bmcl.2007.11.054 | Unchecked | 7 |
| 17585747 | 10.1021/jm061366a | A549 | 1 |
| 18077159 | 10.1016/j.bmcl.2007.11.054 | NON-PROTEIN TARGET | 1 |
| 18077159 | 10.1016/j.bmcl.2007.11.054 | PANC-1 | 1 |
| 18077159 | 10.1016/j.bmcl.2007.11.054 | CCRF-CEM | 1 |
Data from ChEMBL 36 via Core Engine